- Home
- Publications
- Publication Search
- Publication Details
Title
The Impact of THC and CBD in Schizophrenia: A Systematic Review
Authors
Keywords
-
Journal
Frontiers in Psychiatry
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-07-23
DOI
10.3389/fpsyt.2021.694394
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cannabidiol modulation of hippocampal glutamate in early psychosis
- (2021) Aisling O’Neill et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
- (2021) F. Markus Leweke et al. Frontiers in Pharmacology
- Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
- (2021) Francesco Bartoli et al. Journal of Clinical Medicine
- Cannabidiol as a treatment option for schizophrenia
- (2020) Julie Schoevers et al. CURRENT OPINION IN PSYCHIATRY
- Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
- (2020) Aisling O'Neill et al. PSYCHOLOGICAL MEDICINE
- Cannabidiol for the treatment of psychosis among patients with schizophrenia and other primary psychotic disorders: A systematic review with a risk of bias assessment
- (2020) Maykel Farag Ghabrash et al. PSYCHIATRY RESEARCH
- A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
- (2019) Nadia Solowij et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
- (2019) Albert Batalla et al. Journal of Clinical Medicine
- Cannabidiol (CBD) use in psychiatric disorders: A systematic review
- (2019) Stefania Bonaccorso et al. NEUROTOXICOLOGY
- Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
- (2019) Robin Wilson et al. Translational Psychiatry
- Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
- (2018) Philip McGuire et al. AMERICAN JOURNAL OF PSYCHIATRY
- Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
- (2018) Musa Basseer Sami et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Risks and Benefits of Marijuana Use
- (2018) Salomeh Keyhani et al. ANNALS OF INTERNAL MEDICINE
- Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
- (2018) Sagnik Bhattacharyya et al. JAMA Psychiatry
- Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
- (2017) Douglas L Boggs et al. NEUROPSYCHOPHARMACOLOGY
- US Epidemiology of Cannabis Use and Associated Problems
- (2017) Deborah S Hasin NEUROPSYCHOPHARMACOLOGY
- A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
- (2017) Ashleigh L. Osborne et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Symptomatic and functional outcomes of substance use disorder persistence 2 years after admission to a first-episode psychosis program
- (2017) Amal Abdel-Baki et al. PSYCHIATRY RESEARCH
- Understanding marijuana's effects on functional connectivity of the default mode network in patients with schizophrenia and co-occurring cannabis use disorder: A pilot investigation
- (2017) Susan Whitfield-Gabrieli et al. SCHIZOPHRENIA RESEARCH
- Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions–III
- (2016) Deborah S. Hasin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Human Laboratory Studies on Cannabinoids and Psychosis
- (2016) Mohamed Sherif et al. BIOLOGICAL PSYCHIATRY
- Changes in Cannabis Potency Over the Last 2 Decades (1995–2014): Analysis of Current Data in the United States
- (2016) Mahmoud A. ElSohly et al. BIOLOGICAL PSYCHIATRY
- Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
- (2016) Arianna Marconi et al. SCHIZOPHRENIA BULLETIN
- Erratum: Erratum: Cannabis and tolerance: acute drug impairment as a function of cannabis use history
- (2016) J. G. Ramaekers et al. Scientific Reports
- Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis
- (2015) Margaret Haney et al. NEUROPSYCHOPHARMACOLOGY
- Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC
- (2014) Adina S. Fischer et al. SCHIZOPHRENIA RESEARCH
- Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint
- (2013) Marie Fabritius et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Comparison of Cannabinoid Pharmacokinetic Properties in Occasional and Heavy Users Smoking a Marijuana or Placebo Joint
- (2013) S. W. Toennes et al. JOURNAL OF ANALYTICAL TOXICOLOGY
- Cannabis use and vulnerability for psychosis in early adolescence-a TRAILS study
- (2012) Merel F. H. Griffith-Lendering et al. ADDICTION
- Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
- (2012) Amir Englund et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Acute effects of THC on time perception in frequent and infrequent cannabis users
- (2012) R. Andrew Sewell et al. PSYCHOPHARMACOLOGY
- Evidence That Psychotic Symptoms Are Prevalent in Disorders of Anxiety and Depression, Impacting on Illness Onset, Risk, and Severity--Implications for Diagnosis and Ultra-High Risk Research
- (2012) J. T. W. Wigman et al. SCHIZOPHRENIA BULLETIN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Neural correlates of cognitive impairment in schizophrenia
- (2011) Jordi Ortiz-Gil et al. BRITISH JOURNAL OF PSYCHIATRY
- GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
- (2011) Gordon H. Guyatt et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Cannabis with high cannabidiol content is associated with fewer psychotic experiences
- (2011) Christian D. Schubart et al. SCHIZOPHRENIA RESEARCH
- Functional resting-state networks are differentially affected in schizophrenia
- (2011) Neil D. Woodward et al. SCHIZOPHRENIA RESEARCH
- Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder
- (2010) Serge Sevy et al. ACTA PSYCHIATRICA SCANDINAVICA
- Brain Network Connectivity in Individuals with Schizophrenia and Their Siblings
- (2010) Grega Repovs et al. BIOLOGICAL PSYCHIATRY
- Psychosis reactivity to cannabis use in daily life: an experience sampling study
- (2010) Cécile Henquet et al. BRITISH JOURNAL OF PSYCHIATRY
- Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD)
- (2010) Jaime E. C. Hallak et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Examining a Cognitive Model of Persecutory Ideation in the Daily Life of People With Schizophrenia: A Computerized Experience Sampling Study
- (2010) D. Ben-Zeev et al. SCHIZOPHRENIA BULLETIN
- The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
- (2010) M. Yucel et al. SCHIZOPHRENIA BULLETIN
- Alterations in functional activation in euthymic bipolar disorder and schizophrenia during a working memory task
- (2009) Liberty S. Hamilton et al. HUMAN BRAIN MAPPING
- Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
- (2009) Sagnik Bhattacharyya et al. NEUROPSYCHOPHARMACOLOGY
- Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia
- (2009) S. Whitfield-Gabrieli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning
- (2009) P. D. Morrison et al. PSYCHOLOGICAL MEDICINE
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
- (2009) J. Koskinen et al. SCHIZOPHRENIA BULLETIN
- How Prevalent Are Anxiety Disorders in Schizophrenia? A Meta-Analysis and Critical Review on a Significant Association
- (2009) A. M. Achim et al. SCHIZOPHRENIA BULLETIN
- Association of cannabis use with prodromal symptoms of psychosis in adolescence
- (2008) Jouko Miettunen et al. BRITISH JOURNAL OF PSYCHIATRY
- Effects of cannabis use on outcomes of psychotic disorders: systematic review
- (2008) Stanley Zammit et al. BRITISH JOURNAL OF PSYCHIATRY
- Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis
- (2008) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Reward Processing in Schizophrenia: A Deficit in the Representation of Value
- (2008) J. M. Gold et al. SCHIZOPHRENIA BULLETIN
- Psychiatric Comorbidities and Schizophrenia
- (2008) P. F. Buckley et al. SCHIZOPHRENIA BULLETIN
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now